Koch E
Department of Pharmacology, Dr. Willmar Schwabe Arzneimittel GmbH, Karlsruhe, Germany.
Planta Med. 2001 Aug;67(6):489-500. doi: 10.1055/s-2001-16496.
Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are very common disorders in aging men. Despite the great clinical importance, many aspects of their aetiology remain uncertain although it is generally accepted that advanced age and testicular androgens are important requirements for the development of these complaints. The currently available therapeutic options include watchful waiting, changes of life style, medical treatments and invasive therapies. In many European countries the use of phytopharmaceuticals for the management of BPH and related LUTS is common and these products represent up to 80 % of all drugs prescribed for this disorder. In particularly, extracts from the fruits of saw palmetto (Sabal serrulata, syn. Serenoa repens) and the roots of stinging nettle (Urtica dioica) are popular. During the last years numerous papers have been published which elaborated on the pharmacological activities and the clinical assessment of these herbal remedies. These investigations have not only broadened the scientific basis for the rational use of phytotherapeutics but have also provided evidence for their therapeutic efficacy and favourable safety profile.
良性前列腺增生(BPH)及相关下尿路症状(LUTS)是老年男性中非常常见的疾病。尽管具有重大的临床意义,但其病因的许多方面仍不明确,不过人们普遍认为高龄以及睾丸雄激素是这些病症发生的重要条件。目前可用的治疗选择包括观察等待、生活方式改变、药物治疗和侵入性治疗。在许多欧洲国家,使用植物药治疗BPH及相关LUTS很常见,这些产品占治疗该疾病所开所有药物的80%。特别是,锯叶棕(沙巴棕,同义词锯齿棕)果实提取物和荨麻(异株荨麻)根提取物很受欢迎。在过去几年里,发表了大量论文,阐述了这些草药的药理活性和临床评估。这些研究不仅拓宽了合理使用植物疗法的科学基础,还为其治疗效果和良好的安全性提供了证据。